SCHEMBL13619476

SCHEMBL13619476

COC(=O)c1ccc2nnn(CCCC(C)(C)[Si](C)(C)O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
HCAR3 P49019 5/20 0.41
ACSS2 Q9NR19 1/20 0.40
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK10 P53779 1/20 0.39
KMO O15229 1/20 0.38
BRD4 O60885 1/20 0.37
MAPK1 P28482 1/20 0.37
MGAM O43451 1/20 0.36
AMY1A P0DUB6 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17103115 0.81 HCAR3 (0.47) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL12421884 0.80 NPC1 (0.49) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL12380477 0.79 HCAR3 (0.46) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL12421886 0.78 SLC9A1 (0.38) NPC1RAB9AHCAR3MAPTKMO
SCHEMBL6184141 0.77 HCAR3 (0.56) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL27965846 0.75 HCAR3 (0.40) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL15687432 0.74 MAPT (0.53) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL2884485 0.73 HCAR3 (0.53) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL31377132 0.72 LMNA (0.44) LMNATSHRNPSR1NPC1RAB9A
SCHEMBL12421885 0.70 HCAR3 (0.58) LMNATSHRNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009140553-A2 HYPOXIA ACTIVATED DRUGS OF NITROGEN MUSTARD ALKYLATORS THRESHOLD PHARMACEUTICALS, INC. (US) 2009-11-19 WO disclosed